Bank Of New York Mellon Corp Aytu Biopharma, Inc Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.15 - $4.0 $1,562 - $41,656	10,414 New	10,414 $1,000
Q3 2021 Nov 12, 2021	SELL	$2.78 - $5.12 $15,303 - $28,185	-5,505 Reduced 34.58%	10,414 $30,000
Q2 2021 Aug 11, 2021	SELL	$4.73 - $7.56 $146,223 - $233,709	-30,914 Reduced 66.01%	15,919 $79,000
Q1 2021 May 13, 2021	BUY	$6.23 - $9.88 $199,210 - $315,922	31,976 Added 215.23%	46,833 $355,000
Q4 2020 Feb 09, 2021	BUY	$5.98 - $13.5 $88,844 - $200,569	14,857 New	14,857 $88,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $88.7M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.